This strategic collaboration will leverage Harbour BioMed』s innovative H2L2 platform with Wistar』s fundamental research expertise in cancer biology and immunology to generate fully human monoclon…
Harbour BioMed and The Wistar Institute Join Forces to Advance Novel Antibody Therapies for Cancer and Infectious Diseases
This strategic collaboration will leverage Harbour BioMed』s innovative H2L2 platform with Wistar』s fundamental research expertise in cancer biology and immunology to generate fully human monoclon…